Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 8/20 | 0.35 |
| ▸ | CES1 | P23141 | 5/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.34 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL31621177 | 0.98 | MAPT (0.40) | MAPTCA2MAPK1CA1FAAH | |
| SCHEMBL28409179 | 0.93 | MAPT (0.52) | MAPTFAAHCES1GPR84CES2 | |
| SCHEMBL8490371 | 0.93 | MAPT (0.52) | MAPTFAAHCES1GPR84CES2 | |
| SCHEMBL5690760 | 0.93 | MAPT (0.52) | MAPTFAAHCES1GPR84CES2 | |
| SCHEMBL3132066 | 0.89 | MAPT (0.39) | MAPTCA2MAPK1CA1FAAH | |
| SCHEMBL28363304 | 0.87 | THRB (0.39) | MAPTCA2MAPK1CA1FAAH | |
| SCHEMBL28408481 | 0.84 | F7 (0.46) | MAPTFAAHCES1CYP1A2KMT2A | |
| SCHEMBL29203315 | 0.84 | MAPT (0.46) | MAPTFAAHCES1GPR84CES2 | |
| SCHEMBL431608 | 0.83 | MAPT (0.36) | MAPTCA2MAPK1CA1FAAH | |
| SCHEMBL29740036 | 0.82 | MAPT (0.49) | MAPTFAAHCES1GPR84CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022142152-A1 | CONTENT MEASUREMENT METHOD FOR CLINDAMYCIN PHOSPHATE VAGINAL TABLET | 海南海神同洲制药有限公司 | 2022-07-07 | — | — | WO | claimed |
| CN-119080010-A | Preparation method and application of organic fluorine modified nano fumed silica | 湖北汇富纳米材料股份有限公司 | 2024-12-06 | — | — | CN | disclosed |
| WO-2022142152-A1 | CONTENT MEASUREMENT METHOD FOR CLINDAMYCIN PHOSPHATE VAGINAL TABLET | 海南海神同洲制药有限公司 | 2022-07-07 | — | — | WO | disclosed |
| WO-2021147585-A1 | USE OF CHITOSAN MODIFIED BY FLUORINE-CONTAINING COMPOUND AS DRUG CARRIER AND PREPARATION METHOD THEREFOR | 苏州大学 | 2021-07-29 | — | — | WO | disclosed |
| US-10758490-B2 | Nanocapsules containing microemulsions | LIPOTEC, S.A. (ES) | 2020-09-01 | — | — | US | disclosed |
| EP-2618926-B1 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC SA (ES) | 2019-05-08 | — | — | EP | disclosed |
| EP-3272398-A1 | LIPID NANOPARTICLE CAPSULES | Lipotec S.A. (ES) | 2018-01-24 | — | — | EP | disclosed |
| EP-2898774-A1 | Composition for the treatment of textile materials | Archroma IP GmbH (CH) | 2015-07-29 | — | — | EP | disclosed |
| US-8921515-B2 | Methods and compositions of preparation for proteome analysis | CASE WESTERN RESERVE UNIVERSITY (US) | 2014-12-30 | — | — | US | disclosed |
| US-20130216596-A1 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC, S.A. (ES) | 2013-08-22 | — | — | US | disclosed |
| EP-2618926-A2 | NANOCAPSULES CONTAINING MICROEMULSIONS | Lipotec, S.A. (ES) | 2013-07-31 | — | — | EP | disclosed |
| US-20130172539-A1 | METHODS AND COMPOSITIONS OF PREPARATION FOR PROTEOME ANALYSIS | CASE WESTERN RESERVE UNIVERSITY (US) | 2013-07-04 | — | — | US | disclosed |
| EP-2549977-A2 | LIPID NANOPARTICLE CAPSULES | Lipotec, S.A. (ES) | 2013-01-30 | — | — | EP | disclosed |
| US-20130017239-A1 | LIPID NANOPARTICLE CAPSULES | LIPOTEC S.A. (ES) | 2013-01-17 | — | — | US | disclosed |
| WO-2012038061-A2 | NANOCAPSULES CONTAINING MICROEMULSIONS | LIPOTEC, S.A. (ES) | 2012-03-29 | — | — | WO | disclosed |
| WO-2011116963-A2 | LIPID NANOPARTICLE CAPSULES | LIPOTEC S.A. (ES) | 2011-09-29 | — | — | WO | disclosed |